University Hospital, Strasbourg, France: Shock, Septic trials

The registry lists 10 Shock, Septic studies with University Hospital, Strasbourg, France as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• EARLY DIAGNOSIS OF SEPTIC DICNot yet recruitingNCT07630415
• Fluorescent Leukocytes as a Marker of Early Sepsis/SeverityNot yet recruitingNCT07585942
• Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory DysfunctionNot yet recruitingNCT07488689Phase 3
• Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in AlsaceRecruitingNCT07312474
• Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic CoagulopathyNot yet recruitingNCT07214103Phase 2
• Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory FailureRecruitingNCT06881927Phase 4
• Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility StudyCompletedNCT04580563Not applicable
• Study of the Role of Interferon αon the Endothelial Dysfunction During Septic ShockStatus unknownNCT04204694
• Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical RelevanceStatus unknownNCT02391792
• Membrane Shedding During Septic ShockCompletedNCT01604551